Amundi Replimune Group, Inc. Transaction History

Amundi

$253 Billion
Q2 2024

A detailed history of Amundi transactions in Replimune Group, Inc. stock. As of the latest transaction made, Amundi holds 2,513 shares of REPL stock, worth $28,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,513

Previous 248,080 98.99%

Holding current value

$28,045

Previous $2.03 Million 98.91%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $1.23 Million - $2.32 Million	-245,567 Reduced 98.99%	2,513 $22,000
Q1 2024 May 15, 2024	BUY	$6.87 - $9.31 $505,851 - $685,513	73,632 Added 42.21%	248,080 $2.03 Million
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $2.75 Million - $6.6 Million	-407,640 Reduced 70.03%	174,448 $1.47 Million
Q3 2023 Nov 14, 2023	BUY	$15.96 - $22.18 $2.08 Million - $2.88 Million	130,041 Added 28.77%	582,088 $9.96 Million
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $783,000 - $1.21 Million	50,032 Added 12.45%	452,047 $10.5 Million
Q1 2023 May 15, 2023	SELL	$17.48 - $29.09 $339,583 - $565,131	-19,427 Reduced 4.61%	402,015 $7.1 Million
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $961,842 - $1.57 Million	56,281 Added 15.41%	421,442 $11.5 Million
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $139,651 - $189,334	-8,952 Reduced 2.39%	365,161 $6.44 Million
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $762,689 - $1.14 Million	57,259 Added 18.07%	374,113 $7.57 Million
Q1 2022 May 16, 2022	SELL	$15.24 - $29.75 $321,122 - $626,862	-21,071 Reduced 6.24%	316,854 $6.27 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $421,934 - $568,276	-16,592 Reduced 4.68%	337,925 $7.88 Million
Q3 2021 Nov 15, 2021	BUY	$28.98 - $39.54 $2.34 Million - $3.2 Million	80,822 Added 29.53%	354,517 $10.5 Million
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $7.8 Million - $10.8 Million	273,695 New	273,695 $10.5 Million

Others Institutions Holding REPL

# of Institutions

153

Shares Held

70M

Call Options Held

26.7K

Put Options Held

28.6K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $550M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account